MINT-LEVOCARB
MINT PHARMACEUTICALS INC
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of MINT-LEVOCARB in Canada?
Yes. MINT-LEVOCARB 25MG 250MG has an active shortage reported to Health Canada (last updated June 17, 2026).
Why is MINT-LEVOCARB not available?
The reason the manufacturer reported: Requirements related to complying with good manufacturing practices.
When will MINT-LEVOCARB be available again?
The manufacturer's estimated resolution date is November 30, 2026. This is an estimate and can change; follow this page to get an email when the status changes.
What this means
Does this mean my pharmacy is out of stock?
Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.
What should I do?
Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.
Estimated Resolution
2026-11-30
~2 months remaining (estimate)
This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.
DIN
02457970
Strength
25MG 250MG
Dosage Form
TABLET
Route
ORAL
Active Ingredient
CARBIDOPA LEVODOPA
Tier
Unrated
Last Updated
2026-06-17
Reason for Shortage
Requirements related to complying with good manufacturing practices.
Other Products from MINT PHARMACEUTICALS INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
300MG · DIN 02480956
25MG · DIN 02468859
10MG · DIN 02468840
200MG · DIN 02524708
800MG · DIN 02524724
400MG · DIN 02524716
70.0MG · DIN 02394871
10MG · DIN 02362678
5MG · DIN 02362651
1MG · DIN 02393573
5MG · DIN 02495449
2.5MG · DIN 02495430